Skip to main content
Equibles
AHR logo

AHR · American Healthcare REIT, Inc. · Documents

Track AHR — free

Use AHR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AHR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$57.78 -0.86 (-1.47%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$13.41B
Shares
232.07M
Volume · Nov 13 2.58M Avg daily vol (3M) 3.1M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $2.26B up 9.1% 10-K filed Feb 27, 2026 Quarterly report FY2026 Q3 Revenue $742.15M up 29.5% 10-Q filed Nov 6, 2026 Latest results Raises 2026 Guidance After 13.8% Same-Store NOI Growth 8-K filed Nov 5, 2026 Earnings call Q3 2026 earnings call Held Nov 6, 2026
2026
Nov 6
Current report 8-K
$1,750,000,000 ATM Common Stock Offering Launched

American Healthcare REIT, Inc. launched a $1,750,000,000 ATM common stock offering on November 6, 2026, terminating its prior program with approximately $170,134,000 remaining unsold.

Entered into a material agreement Read from the first part of this long document
2 source passages
On November 6, 2026, we and American Healthcare REIT Holdings, LP, or our Operating Partnership, entered into an ATM Equity Offering Sales Agreement, or the Sales Agreement, with BofA Securities, Inc., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Credit Agricole Securities (USA) Inc., Fifth Third Securities, Inc., KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC and Truist Securities, Inc., or each, an Agent, and, collectively, the Agents, and the Forward Purchasers (as defined below), providing for the offer and sale of shares of our common stock, $0.01 par value per share, or Common Stock, having an aggregate gross sales price of up to $1,750,000,000, or the Shares, through the Agents, as our sales agents or, if applicable, as forward sellers, or directly to the Agents as principals. Upon entry into the Sales Agreement, we terminated our prior at-the-market offering program and the related ATM Equity Offering Sales Agreement, dated as of February 27, 2026, or the Prior Sales Agreement, entered into with the agents and forward purchasers named therein. At the time of the termination of the Prior Sales Agreement, approximately $170,134,000 remained unsold under the Prior Sales Agreement. Open the document at this passage
Nov 6
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises as portfolio reaches 366 buildings

American Healthcare REIT, Inc. reported nine-month 2026 revenue of $2,067,173 thousand, up from $1,656,043 thousand in 2025, driven by acquisitions and higher resident occupancy. As of September 30, 2026, its portfolio comprised 366 buildings totaling approximately 25,437,000 square feet.

Revenue $742.15M ▲ 29.5% Net income $31.21M ▼ 44.2% Diluted EPS $0.14 ▼ 57.6%
Read from the MD&A section
5 source passages
American Healthcare REIT, Inc., a Maryland corporation, is a self-managed REIT that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties As of September 30, 2026, we owned and/or operated 366 buildings and ISHC, which represent in total approximately 25,437,000 square feet of gross leasable area, or GLA, for an aggregate contract purchase price of $7,426,645,000. Revenues by reportable segment consisted of the following for the periods presented below (in thousands): Nine Months Ended September 30, | 2026 | 2025 Total revenues | 742,149 | 572,937 | 2,067,173 | 1,656,043 Open the document at this passage
Nov 6
Earnings call
Raises 2026 NFFO guidance as same-store NOI reaches 13.8 percent

American Healthcare REIT raised full-year 2026 NFFO per diluted share guidance to $223 to $226 from $215 to $219 after third-quarter same-store NOI grew 13.8 percent; net debt to annualized adjusted EBITDA improved to 1.9 times.

Read from the first part of this long document
4 source passages
Good morning. Thank you for joining us for American Healthcare REIT's third quarter 2026 earnings conference call. Total same-store NOI growth of 13.8 percent Given these results, we are now raising full-year 2026 NFFO per diluted share guidance to a range of $223 to $226, up from our prior range of $215 to $219. Net debt to annualized adjusted EBITDA improved to 1.9 times, half a turn lower sequentially and 1.6 turns lower than a year ago. Open the document at this passage
Nov 5
Current report 8-K
Raises 2026 Guidance After 13.8% Same-Store NOI Growth

American Healthcare REIT, Inc. reported third-quarter NFFO of $0.58 per diluted share and 13.8% Same-Store NOI growth, raising 2026 NFFO guidance to $2.23 to $2.26 and Same-Store NOI growth guidance to 12.0% to 14.0%.

Financial results, Regulation FD disclosure Read from the first part of this long document
4 source passages
American Healthcare REIT, Inc. is announcing today its third quarter 2026 results and increasing full year 2026 guidance. Normalized Funds From Operations attributable to controlling interest (“NFFO”) of $0.58 per diluted share. Achieved total portfolio Same-Store Net Operating Income (“Same-Store NOI”) growth of 13.8%. Increased total portfolio Same-Store NOI growth guidance to 12.0% to 14.0% and NFFO per diluted share guidance to $2.23 to $2.26 for the year ending December 31, 2026. Open the document at this passage
Aug 24
Current report 8-K Events of Aug 20
Other events AI summary on its way
Aug 12
Current report 8-K Events of Aug 10
Other events AI summary on its way
Aug 7
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $674.25M ▲ 24.3% Net income $30.61M ▲ 208.9% Diluted EPS $0.16 ▲ 166.7%
May 28
Current report 8-K Events of May 26
Other events AI summary on its way
May 22
Current report 8-K Events of May 20
Other events AI summary on its way
May 8
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $650.77M ▲ 20.4% Net income $23.71M Diluted EPS $0.13
Feb 27
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $2.26B ▲ 9.1% Net income $69.81M Diluted EPS $0.42
2025
Aug 8
Quarterly report 10-Q FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $542.5M ▲ 7.5% Net income $9.91M ▲ 400.7% Diluted EPS $0.06 ▲ 500.0%
Showing 1–50 of 185 documents
Key facts CIK 1632970 CUSIP 398182303 13F (30d) 477 filings 438 filers Visit website Investor relations